This blog explains the top five financial KPIs that founders should focus on in 2025. From cash flow to efficiency ratios, it highlights why these metrics matter and how GATP Solutions helps turn insights into action.
Top 5 Financial KPIs Every Founder Should Track in 2025 Read More »
Accurate 340B financial reporting is essential for US covered entities. This blog explores the financial stakes, audit risks, state requirements, and how GATP Solutions supports compliance and sustainability.
Why Accurate 340B Financial Reporting Matters For US Covered Entities Read More »
The 340B Drug Pricing Program has grown rapidly, with over 60,000 covered entities as of 2025 and billions in drug discounts. For multi-clinic entities, accurate 340B reporting is critical to remain compliant and maximize savings. This blog explores governance, technology, and compliance strategies, while showing how GATP Solutions helps providers streamline reporting across all sites.
How to Streamline 340B Reporting for Multi-Clinic Entities Read More »
The 340B program helps providers stretch resources by accessing discounted drugs, but compliance in 2025 is tougher than ever with stricter HRSA audits and manufacturer scrutiny. This guide explains program requirements, audit challenges, and best practices, while showing how GATP Solutions supports providers with accounting-led compliance and audit readiness.
The Ultimate Guide to 340B Program Compliance in 2025 Read More »
Choosing between in-house and outsourcing accounting can shape how well your business grows and stays compliant. This blog breaks down both models, their pros and cons, and how to pick the right one for your company.
In-House vs Outsourcing Accounting: What Should Your Business Choose? Read More »